📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: EpiCapture

1.1 - Company Overview

EpiCapture Logo

EpiCapture

Headquarter: Ireland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of accurate, non-invasive urine tests to detect aggressive cancers, focused on improving cancer patient care.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to EpiCapture

Nanovi Logo

Nanovi

HQ: Denmark Website
  • Description: Provider of biomaterials-based medical devices for improving guidance and precision in cancer radiotherapy. Offers BioXmark, a liquid fiducial marker that enhances target visibility on imaging for high-precision radiation therapy, including proton beam therapy; and PetXmark, a liquid fiducial marker for dogs and cats to radiographically mark subcutaneous tissue and guide radiotherapy of skin and subcutaneous tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nanovi company profile →
Dako Logo

Dako

HQ: Denmark Website
  • Description: Provider of reagents, instruments, and software for cancer diagnostics to hospital and research laboratories, offering pathology solutions including diagnostic antibodies, IHC/ISH and flow cytometry reagents; staining and image analysis instruments; molecular and companion diagnostics; and pharmacodiagnostic kits (pharmDx).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Dako company profile →
Kronos Bio Logo

Kronos Bio

HQ: United States Website
  • Description: Provider of oncology therapies that modulate historically undruggable cancer targets. Pipeline includes KB-0742, a CDK9 inhibitor in phase 1/2 for MYC-dependent tumors, and KB-9558 targeting the p300 KAT domain for multiple myeloma. Offers a Small Molecule Microarray screening platform for transcription factor binding assays and a discovery collaboration with Genentech.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kronos Bio company profile →
Estrella Biopharma Logo

Estrella Biopharma

HQ: United States Website
  • Description: Provider of proprietary CD19-Redirected ARTEMIS T-cell therapies for cancer, designed to treat CD19-positive blood cancers with reduced risk of CRS and neurotoxicity. Offerings include a Mark-and-Kill approach using an oncolytic virus to label solid tumors for targeting by ARTEMIS T Cells, EB104 (CD19/CD22) for blood cancers, and EB103 combined with an oncolytic virus for solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Estrella Biopharma company profile →
Arvinas Logo

Arvinas

HQ: United States Website
  • Description: Provider of PROTAC protein degrader therapies that harness the body's natural protein disposal system to degrade disease-causing proteins for life-threatening diseases, from discovery to commercialization. Pipeline includes vepdegestrant (ER+ breast cancer), ARV-766 (licensed to Novartis; prostate cancer), ARV-393 (BCL6), ARV-102 (LRRK2), and alpha-synuclein degraders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arvinas company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for EpiCapture

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to EpiCapture

2.2 - Growth funds investing in similar companies to EpiCapture

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for EpiCapture

4.2 - Public trading comparable groups for EpiCapture

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to EpiCapture

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About EpiCapture

What does EpiCapture do?

EpiCapture is a provider of accurate, non-invasive urine tests to detect aggressive cancers, focused on improving cancer patient care.

Who are EpiCapture's competitors?

EpiCapture's competitors and similar companies include Nanovi, Dako, Kronos Bio, Estrella Biopharma, and Arvinas.

Where is EpiCapture headquartered?

EpiCapture is headquartered in Ireland.

How many employees does EpiCapture have?

EpiCapture has 1,000 employees 🔒.

When was EpiCapture founded?

EpiCapture was founded in 2010 🔒.

What sector and industry vertical is EpiCapture in?

EpiCapture is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for EpiCapture

Who are the top strategic acquirers in EpiCapture's sector and industry

Top strategic M&A buyers and acquirers in EpiCapture's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for EpiCapture?

Top strategic M&A buyers groups and sectors for EpiCapture include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in EpiCapture's sector and industry vertical

Which are the top PE firms investing in EpiCapture's sector and industry vertical?

Top PE firms investing in EpiCapture's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in EpiCapture's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in EpiCapture's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in EpiCapture's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to EpiCapture include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in EpiCapture's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for EpiCapture?

The key public trading comparables and valuation benchmarks for EpiCapture include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for EpiCapture for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for EpiCapture with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in EpiCapture's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for EpiCapture with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in EpiCapture's' sector and industry vertical?

Access recent funding rounds and capital raises in EpiCapture's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for EpiCapture